ZA200105406B - Method of producing cyclene. - Google Patents
Method of producing cyclene. Download PDFInfo
- Publication number
- ZA200105406B ZA200105406B ZA200105406A ZA200105406A ZA200105406B ZA 200105406 B ZA200105406 B ZA 200105406B ZA 200105406 A ZA200105406 A ZA 200105406A ZA 200105406 A ZA200105406 A ZA 200105406A ZA 200105406 B ZA200105406 B ZA 200105406B
- Authority
- ZA
- South Africa
- Prior art keywords
- hours
- cyclene
- process according
- solvent
- reaction
- Prior art date
Links
- RRBYUSWBLVXTQN-UHFFFAOYSA-N tricyclene Chemical compound C12CC3CC2C1(C)C3(C)C RRBYUSWBLVXTQN-UHFFFAOYSA-N 0.000 title claims abstract description 43
- RRBYUSWBLVXTQN-VZCHMASFSA-N tricyclene Natural products C([C@@H]12)C3C[C@H]1C2(C)C3(C)C RRBYUSWBLVXTQN-VZCHMASFSA-N 0.000 title claims abstract description 41
- 238000000034 method Methods 0.000 title claims abstract description 40
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 73
- 238000006243 chemical reaction Methods 0.000 claims description 46
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 42
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 36
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 claims description 34
- 239000002904 solvent Substances 0.000 claims description 25
- 238000010992 reflux Methods 0.000 claims description 23
- 238000001704 evaporation Methods 0.000 claims description 21
- 230000008020 evaporation Effects 0.000 claims description 21
- VILCJCGEZXAXTO-UHFFFAOYSA-N 2,2,2-tetramine Chemical compound NCCNCCNCCN VILCJCGEZXAXTO-UHFFFAOYSA-N 0.000 claims description 19
- 229940015043 glyoxal Drugs 0.000 claims description 17
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 claims description 11
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 11
- KLKFAASOGCDTDT-UHFFFAOYSA-N ethoxymethoxyethane Chemical compound CCOCOCC KLKFAASOGCDTDT-UHFFFAOYSA-N 0.000 claims description 11
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 10
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 9
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 8
- PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 6
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 6
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 5
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 5
- 239000002168 alkylating agent Substances 0.000 claims description 5
- 229940100198 alkylating agent Drugs 0.000 claims description 5
- 239000003586 protic polar solvent Substances 0.000 claims description 5
- AVQQQNCBBIEMEU-UHFFFAOYSA-N 1,1,3,3-tetramethylurea Chemical compound CN(C)C(=O)N(C)C AVQQQNCBBIEMEU-UHFFFAOYSA-N 0.000 claims description 4
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- GUVUOGQBMYCBQP-UHFFFAOYSA-N dmpu Chemical compound CN1CCCN(C)C1=O GUVUOGQBMYCBQP-UHFFFAOYSA-N 0.000 claims description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 4
- GBBZLMLLFVFKJM-UHFFFAOYSA-N 1,2-diiodoethane Chemical compound ICCI GBBZLMLLFVFKJM-UHFFFAOYSA-N 0.000 claims description 3
- 150000001412 amines Chemical class 0.000 claims description 3
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 claims description 3
- 239000000920 calcium hydroxide Substances 0.000 claims description 3
- 229910001861 calcium hydroxide Inorganic materials 0.000 claims description 3
- 239000007859 condensation product Substances 0.000 claims description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- QJNULWKDWXIXLJ-UHFFFAOYSA-N 1,2-bis(methylsulfonyl)ethane Chemical compound CS(=O)(=O)CCS(C)(=O)=O QJNULWKDWXIXLJ-UHFFFAOYSA-N 0.000 claims description 2
- ATPZFDFVYMLXFX-UHFFFAOYSA-N 1-methyl-4-[2-(4-methylphenyl)sulfonylethylsulfonyl]benzene Chemical compound C1=CC(C)=CC=C1S(=O)(=O)CCS(=O)(=O)C1=CC=C(C)C=C1 ATPZFDFVYMLXFX-UHFFFAOYSA-N 0.000 claims description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- 150000002500 ions Chemical class 0.000 claims description 2
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 claims description 2
- 229910052808 lithium carbonate Inorganic materials 0.000 claims description 2
- QWDJLDTYWNBUKE-UHFFFAOYSA-L magnesium bicarbonate Chemical compound [Mg+2].OC([O-])=O.OC([O-])=O QWDJLDTYWNBUKE-UHFFFAOYSA-L 0.000 claims description 2
- 239000002370 magnesium bicarbonate Substances 0.000 claims description 2
- 235000014824 magnesium bicarbonate Nutrition 0.000 claims description 2
- 229910000022 magnesium bicarbonate Inorganic materials 0.000 claims description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 2
- 239000001095 magnesium carbonate Substances 0.000 claims description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 2
- 235000014380 magnesium carbonate Nutrition 0.000 claims description 2
- 239000003880 polar aprotic solvent Substances 0.000 claims description 2
- 239000011736 potassium bicarbonate Substances 0.000 claims description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 2
- 235000011181 potassium carbonates Nutrition 0.000 claims description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims description 2
- 229940086066 potassium hydrogencarbonate Drugs 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 235000017550 sodium carbonate Nutrition 0.000 claims description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims 2
- 238000006482 condensation reaction Methods 0.000 claims 2
- MHABMANUFPZXEB-UHFFFAOYSA-N O-demethyl-aloesaponarin I Natural products O=C1C2=CC=CC(O)=C2C(=O)C2=C1C=C(O)C(C(O)=O)=C2C MHABMANUFPZXEB-UHFFFAOYSA-N 0.000 claims 1
- 229910000019 calcium carbonate Inorganic materials 0.000 claims 1
- 235000010216 calcium carbonate Nutrition 0.000 claims 1
- 239000007795 chemical reaction product Substances 0.000 claims 1
- 238000005580 one pot reaction Methods 0.000 abstract 1
- 239000007787 solid Substances 0.000 description 21
- 238000003756 stirring Methods 0.000 description 21
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 20
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 20
- 239000000047 product Substances 0.000 description 15
- QBPPRVHXOZRESW-UHFFFAOYSA-N 1,4,7,10-tetraazacyclododecane Chemical compound C1CNCCNCCNCCN1 QBPPRVHXOZRESW-UHFFFAOYSA-N 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 10
- 238000001914 filtration Methods 0.000 description 10
- 239000012528 membrane Substances 0.000 description 10
- 238000003786 synthesis reaction Methods 0.000 description 10
- 230000007062 hydrolysis Effects 0.000 description 6
- 238000006460 hydrolysis reaction Methods 0.000 description 6
- 239000013067 intermediate product Substances 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 239000011575 calcium Substances 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- CASDNPHWJOQUQX-UHFFFAOYSA-N 1-benzylaziridine Chemical compound C=1C=CC=CC=1CN1CC1 CASDNPHWJOQUQX-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- 235000014676 Phragmites communis Nutrition 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229940124530 sulfonamide Drugs 0.000 description 2
- GETTZEONDQJALK-UHFFFAOYSA-N (trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=CC=C1 GETTZEONDQJALK-UHFFFAOYSA-N 0.000 description 1
- APQIUTYORBAGEZ-UHFFFAOYSA-N 1,1-dibromoethane Chemical compound CC(Br)Br APQIUTYORBAGEZ-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229910052688 Gadolinium Inorganic materials 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010959 commercial synthesis reaction Methods 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 229940113088 dimethylacetamide Drugs 0.000 description 1
- OAEGRYMCJYIXQT-UHFFFAOYSA-N dithiooxamide Chemical compound NC(=S)C(N)=S OAEGRYMCJYIXQT-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 1
- RYHQMKVRYNEBNJ-BMWGJIJESA-K gadoterate meglumine Chemical compound [Gd+3].CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC(=O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1 RYHQMKVRYNEBNJ-BMWGJIJESA-K 0.000 description 1
- DPNNNPAKRZOSMO-UHFFFAOYSA-K gadoteridol Chemical compound [Gd+3].CC(O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1 DPNNNPAKRZOSMO-UHFFFAOYSA-K 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- RTWNYYOXLSILQN-UHFFFAOYSA-N methanediamine Chemical compound NCN RTWNYYOXLSILQN-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000039 preparative column chromatography Methods 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 238000006257 total synthesis reaction Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steering Devices For Bicycles And Motorcycles (AREA)
- Tyre Moulding (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Seeds, Soups, And Other Foods (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19856481A DE19856481C1 (de) | 1998-12-02 | 1998-12-02 | Verfahren zur Herstellung von Cyclen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200105406B true ZA200105406B (en) | 2002-07-25 |
Family
ID=7890308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200105406A ZA200105406B (en) | 1998-12-02 | 2001-06-29 | Method of producing cyclene. |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP1135376B1 (cs) |
| JP (1) | JP4636690B2 (cs) |
| KR (1) | KR100639270B1 (cs) |
| CN (1) | CN1155583C (cs) |
| AT (1) | ATE250042T1 (cs) |
| AU (1) | AU764260B2 (cs) |
| CA (1) | CA2353680C (cs) |
| CZ (1) | CZ300157B6 (cs) |
| DE (2) | DE19856481C1 (cs) |
| DK (1) | DK1135376T3 (cs) |
| ES (1) | ES2209530T3 (cs) |
| HK (1) | HK1044148B (cs) |
| IL (1) | IL143079A (cs) |
| NO (1) | NO318054B1 (cs) |
| NZ (1) | NZ512051A (cs) |
| PT (1) | PT1135376E (cs) |
| SK (1) | SK285372B6 (cs) |
| WO (1) | WO2000032581A1 (cs) |
| ZA (1) | ZA200105406B (cs) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2830253B1 (fr) * | 2001-09-28 | 2005-02-04 | Air Liquide | Nouveau procede de preparation de macrocycles azotes c-fonctionnalises et nouveaux intermediaires obtenus |
| CN103360333B (zh) * | 2013-07-22 | 2016-03-30 | 厦门市华兴化工有限公司 | 一种高纯度轮环藤宁的制备方法 |
| CN106490298B (zh) * | 2016-11-28 | 2020-05-22 | 华南理工大学 | 一种高分散性植物蛋白及其制备方法 |
| US10344115B2 (en) | 2017-05-25 | 2019-07-09 | International Business Machines Corporation | Amine glyoxal resins |
| KR20190108383A (ko) | 2018-03-14 | 2019-09-24 | 주식회사 지에이치바이오텍 | 옥사미드 및 수소화알루미늄리튬을 이용한 시클렌의 신규 합성법 |
| EP4067348A1 (en) | 2021-03-30 | 2022-10-05 | Bracco Imaging SPA | Process for the preparation of cyclen |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9504922D0 (en) * | 1995-03-10 | 1995-04-26 | Nycomed As | Process |
| IT1284046B1 (it) * | 1996-06-21 | 1998-05-08 | Bracco Spa | Processo per la preparazione di tetraazamacrocicli |
| IT1290457B1 (it) * | 1997-04-04 | 1998-12-03 | Bracco Spa | Processo per la preparazione di tetraazamacrocicli |
| IT1291673B1 (it) * | 1997-04-28 | 1999-01-19 | Bracco Spa | Processo per la preparazione di 1,4,7,10 - tetraazaciclododecano |
-
1998
- 1998-12-02 DE DE19856481A patent/DE19856481C1/de not_active Expired - Lifetime
-
1999
- 1999-11-17 DE DE59907056T patent/DE59907056D1/de not_active Expired - Lifetime
- 1999-11-17 NZ NZ512051A patent/NZ512051A/en not_active IP Right Cessation
- 1999-11-17 ES ES99959326T patent/ES2209530T3/es not_active Expired - Lifetime
- 1999-11-17 KR KR1020017006832A patent/KR100639270B1/ko not_active Expired - Fee Related
- 1999-11-17 AU AU16543/00A patent/AU764260B2/en not_active Ceased
- 1999-11-17 EP EP99959326A patent/EP1135376B1/de not_active Expired - Lifetime
- 1999-11-17 HK HK02104835.9A patent/HK1044148B/zh not_active IP Right Cessation
- 1999-11-17 WO PCT/EP1999/009089 patent/WO2000032581A1/de active IP Right Grant
- 1999-11-17 JP JP2000585223A patent/JP4636690B2/ja not_active Expired - Fee Related
- 1999-11-17 AT AT99959326T patent/ATE250042T1/de active
- 1999-11-17 SK SK724-2001A patent/SK285372B6/sk not_active IP Right Cessation
- 1999-11-17 IL IL14307999A patent/IL143079A/xx not_active IP Right Cessation
- 1999-11-17 CN CNB998140635A patent/CN1155583C/zh not_active Expired - Fee Related
- 1999-11-17 CZ CZ20011915A patent/CZ300157B6/cs not_active IP Right Cessation
- 1999-11-17 CA CA002353680A patent/CA2353680C/en not_active Expired - Fee Related
- 1999-11-17 DK DK99959326T patent/DK1135376T3/da active
- 1999-11-17 PT PT99959326T patent/PT1135376E/pt unknown
-
2001
- 2001-06-01 NO NO20012703A patent/NO318054B1/no not_active IP Right Cessation
- 2001-06-29 ZA ZA200105406A patent/ZA200105406B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU764260B2 (en) | 2003-08-14 |
| EP1135376B1 (de) | 2003-09-17 |
| CZ20011915A3 (cs) | 2001-09-12 |
| CN1155583C (zh) | 2004-06-30 |
| NZ512051A (en) | 2003-10-31 |
| CA2353680C (en) | 2008-09-09 |
| NO20012703D0 (no) | 2001-06-01 |
| SK7242001A3 (en) | 2001-12-03 |
| ES2209530T3 (es) | 2004-06-16 |
| ATE250042T1 (de) | 2003-10-15 |
| WO2000032581A1 (de) | 2000-06-08 |
| IL143079A0 (en) | 2002-04-21 |
| HK1044148B (zh) | 2005-04-01 |
| SK285372B6 (sk) | 2006-12-07 |
| CN1329603A (zh) | 2002-01-02 |
| KR100639270B1 (ko) | 2006-10-27 |
| PT1135376E (pt) | 2004-02-27 |
| DE19856481C1 (de) | 2000-07-06 |
| EP1135376A1 (de) | 2001-09-26 |
| KR20010080648A (ko) | 2001-08-22 |
| HK1044148A1 (en) | 2002-10-11 |
| NO20012703L (no) | 2001-06-01 |
| AU1654300A (en) | 2000-06-19 |
| JP4636690B2 (ja) | 2011-02-23 |
| DE59907056D1 (de) | 2003-10-23 |
| JP2003522114A (ja) | 2003-07-22 |
| CZ300157B6 (cs) | 2009-02-25 |
| IL143079A (en) | 2005-08-31 |
| CA2353680A1 (en) | 2000-06-08 |
| DK1135376T3 (da) | 2004-01-19 |
| NO318054B1 (no) | 2005-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009185077A (ja) | １，４，７，１０−テトラアザシクロドデカンの製造方法 | |
| AU764260B2 (en) | Method of producing cyclene | |
| CZ304573B6 (cs) | Lithiové komplexy N-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triskarboxymethyl-1,4,7,10-tetraazacyklododekanu a způsob výroby těchto lithiových komplexů a gadobutrolu | |
| US6156890A (en) | Process for the production of cyclene | |
| CN101175764A (zh) | 生产甲基钴胺的方法 | |
| KR100809159B1 (ko) | 로사탄의 개선된 제조방법 | |
| JP2006527241A (ja) | シス−８ｂ−メチルデカヒドロ−２ａ，４ａ，６ａ，８ａ−テトラアザシクロペンタ［ｆｇ］アセナフチレン、シス−デカヒドロ−２ａ，４ａ，６ａ，８ａ−テトラアザシクロペンタ［ｆｇ］アセナフチレン、サイクレンおよび官能化サイクレン | |
| KR100614535B1 (ko) | 1,4,7,10-테트라아자시클로도데칸의 제조 방법 | |
| Thorn et al. | Synthesis of the potentially cytotoxic compound 5-[bis (2-chloroethyl) amino]-1, 3-phenylene biscarbamate | |
| GB1574043A (en) | Dextrorotatory propanones | |
| JP3088561B2 (ja) | ２，３−ジアミノピリジン類の製造方法 | |
| JP2001522362A (ja) | １，４，７，１０−テトラアザシクロドデカンの製造方法 | |
| US4798895A (en) | Process for preparing levomepromazine hydrogen maleate | |
| US3915985A (en) | Process for preparing naphth{8 1,2-d{9 imidazole and intermediate therefor 1-hydroxynaphth{8 1,2-d{9 imidazole hydrate | |
| CA2610665A1 (fr) | Hydrates de sels alcalino-terreux d'irbesartan et leur preparation | |
| Hardtmann et al. | Synthesis of 9, 13b-dihydroisoindolo [2, 1-d][1, 4] benzodiazepin-6-one | |
| JPH01160969A (ja) | ２−置換イミダゾールの分離法 | |
| JPH02240073A (ja) | 光学活性パントラクトンの製造方法 | |
| Grandberg | Synthesis of indolylalkylamines and related compounds from-, δ-halocarbonyls and arylhydrazines | |
| NO130475B (cs) | ||
| WO2010069397A1 (en) | Process for the preparation of diclofenac epolamine |